scPharmaceuticals Inc. to Present at the Piper Jaffray 31st Annual Healthcare Conference
BURLINGTON, Mass.--(BUSINESS WIRE)--Nov 26, 2019--
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, chief executive officer, will present and host investor meetings at the Piper Jaffray 31 st Annual Healthcare Conference being held at the Lotte New York Palace in New York, NY. The Company is scheduled to present on Thursday, December 5, 2019, at 8:50 a.m. ET.
A live webcast of the presentation can be accessed under “News & Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com, and will be archived for ninety days.
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit scPharmaceuticals.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20191126005172/en/
CONTACT: Katherine Taudvin, scPharmaceuticals Inc.
email@example.comChristopher F. Brinzey, Westwicke an ICR Company
KEYWORD: NEW YORK MASSACHUSETTS UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: BIOTECHNOLOGY INFECTIOUS DISEASES HEALTH PHARMACEUTICAL CARDIOLOGY
SOURCE: scPharmaceuticals Inc.
Copyright Business Wire 2019.
PUB: 11/26/2019 08:00 AM/DISC: 11/26/2019 08:01 AM